Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Provided By GlobeNewswire
Last update: Feb 27, 2025
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and provided business highlights.
Read more at globenewswire.com
